Atai Beckley N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
4.180
-0.150 (-3.46%)
Dec 24, 2025, 11:43 AM EST - Market open
Atai Beckley Employees
Atai Beckley had 54 employees as of December 31, 2024. The number of employees decreased by 29 or -34.94% compared to the previous year.
Employees
54
Change (1Y)
-29
Growth (1Y)
-34.94%
Revenue / Employee
$55,889
Profits / Employee
-$2,855,407
Market Cap
1.52B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54 | -29 | -34.94% |
| Dec 31, 2023 | 83 | -50 | -37.59% |
| Dec 31, 2022 | 133 | 46 | 52.87% |
| Dec 31, 2021 | 87 | 52 | 148.57% |
| Dec 31, 2020 | 35 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ATAI News
- 1 day ago - AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) - GlobeNewsWire
- 4 weeks ago - Enhanced Fortifies Executive Leadership Team & Board of Directors - PRNewsWire
- 6 weeks ago - Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression Transcript - Seeking Alpha
- 2 months ago - atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares - GlobeNewsWire
- 2 months ago - Atai Life Sciences And Beckley Psytech: Promising Emerging Leader In Psychedelics - Seeking Alpha
- 2 months ago - atai Life Sciences Announces Pricing of Public Offering of Common Shares - GlobeNewsWire
- 2 months ago - atai Life Sciences Announces Proposed Public Offering of Common Shares - GlobeNewsWire
- 2 months ago - atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression - GlobeNewsWire